Immunoglobulin reduced in thrombogenic agents and preparation thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796770
APP PUB NO 20150210754A1
SERIAL NO

14678319

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an immunoglobulin composition reduced in thrombogenic agents and to methods for its preparation. One method comprises subjecting an immunoglobulin containing solution to a negative cation exchanger chromatography at a pH in the range of higher than 3.8 to equal to or lower than 5.3. The solution can also be subjected to a negative anion exchanger chromatography at a pH in the range of 7 to 8.2.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OMRIX BIOPHARMACEUTICALS LTDBLDG 14 WEIZMANN SCIENCE PARK P O BOX 619 REHOVOT 7610601

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bar, Liliana Rehovot, IL 36 315
Belyaev, Oleg Barnaul, RU 11 46
Meidler, Roberto Rehovot, IL 20 88
Mintz, Roni Moshav Shafir, IL 6 8
Nur, Israel Moshav Timmorim, IL 81 5948

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00